Yongzeng Wang

6.7k total citations · 1 hit paper
22 papers, 2.7k citations indexed

About

Yongzeng Wang is a scholar working on Oncology, Plant Science and Molecular Biology. According to data from OpenAlex, Yongzeng Wang has authored 22 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Plant Science and 6 papers in Molecular Biology. Recurrent topics in Yongzeng Wang's work include CAR-T cell therapy research (10 papers), Plant Virus Research Studies (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). Yongzeng Wang is often cited by papers focused on CAR-T cell therapy research (10 papers), Plant Virus Research Studies (9 papers) and Acute Lymphoblastic Leukemia research (5 papers). Yongzeng Wang collaborates with scholars based in United States, Israel and China. Yongzeng Wang's co-authors include Renier J. Brentjens, Isabelle Rivière, Michel Sadelain, Xiuyan Wang, Jae H. Park, Brigitte Sénéchal, Kevin J. Curran, Craig S. Sauter, Bianca Santomasso and Elena Mead and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Yongzeng Wang

21 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia

2018 1.8k citations Jae H. Park, Isabelle Rivière et al. profile →

Peers

Countries citing papers authored by Yongzeng Wang

Since Specialization

Citations

This map shows the geographic impact of Yongzeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongzeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongzeng Wang more than expected).

Fields of papers citing papers by Yongzeng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongzeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongzeng Wang. The network helps show where Yongzeng Wang may publish in the future.

Co-authorship network of co-authors of Yongzeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yongzeng Wang. A scholar is included among the top collaborators of Yongzeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongzeng Wang. Yongzeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cross-Compatible Embedding and Semantic Consistent Feature Construction for Sketch Re-identification 2022 ·Proceedings of the 30th ACM International Conference on Multimedia ·Yafei Zhang, Yongzeng Wang, Huafeng Li, Shuang Li	23
2	Sustained Remission and Decreased Severity of CAR T-Cell Related Adverse Events: A Pivotal Study Report of CNCT19 (inaticabtagene autoleucel) Treatment in Adult Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia (R/R B-Cell ALL) in China 2022 ·Blood ·Ying Wang, Xudong Wei, Dongmei Yan, Cheng Zhang, Hongsheng Zhou, Chunrong Tong, Heng Mei, Jie Jin, Ting Niu, Aibin Liang, (unknown), Yiping Deng, Wei Jin, (unknown), Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Jianxiang Wang	5
3	CNCT19 for Treatment of Patients with Relapsed Refractory B-Cell Acute Lymphoblastic Leukemia (r/r B-cell ALL) in Children and Adults 2021 ·Blood ·Ying Wang, Xiaojuan Chen, (unknown), Yingchang Mi, Lin Shi, Yongzeng Wang, Changting Haudenschild, Lulu Lv, Xiaofan Zhu, Jianxiang Wang	0
4	Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL 2019 ·JCI Insight ·Mark B. Geyer, Isabelle Rivière, Brigitte Sénéchal, Xiuyan Wang, Yongzeng Wang, Terence J. Purdon, Meier Hsu, Sean M. Devlin, M. Lia Palomba, Elizabeth Halton, Yvette Bernal, Dayenne G. van Leeuwen, Michel Sadelain, Jae H. Park, Renier J. Brentjens	69
5	Autologous CD19-Targeted CAR T Cells in Patients with Residual CLL following Initial Purine Analog-Based Therapy 2018 ·Molecular Therapy ·Mark B. Geyer, Isabelle Rivière, Brigitte Sénéchal, Xiuyan Wang, Yongzeng Wang, Terence J. Purdon, Meier Hsu, Sean M. Devlin, Elizabeth Halton, Nicole Lamanna, Jürgen Rademaker, Michel Sadelain, Renier J. Brentjens, Jae H. Park	60
6	Durable long-term survival of adult patients with relapsed B-ALL after CD19 CAR (19-28z) T-cell therapy. 2017 ·Journal of Clinical Oncology ·Jae Hong Park, Isabelle Rivière, Xiuyan Wang, Brigitte Sénéchal, Yongzeng Wang, Elena Mead, Bianca Santomasso, Elizabeth Halton, Claudia Diamonte, Yvette Bernal, Daniel Li, Michel Sadelain, Renier J. Brentjens	13
7	Baseline and early post-treatment clinical and laboratory factors associated with severe neurotoxicity following 19-28z CAR T cells in adult patients with relapsed B-ALL. 2017 ·Journal of Clinical Oncology ·Jae Hong Park, Bianca Santomasso, Isabelle Rivière, Brigitte Sénéchal, Xiuyan Wang, Terence J. Purdon, Yongzeng Wang, Elizabeth Halton, Claudia Diamonte, Daniel Li, Michel Sadelain, Renier J. Brentjens	20
8	A phase I trial of CD19-targeted EGFRt/19-28z/4-1BBL armored chimeric antigen receptor (CAR) modified T cells in patients with relapsed or refractory chronic lymphocytic leukemia. 2017 ·Journal of Clinical Oncology ·Jae Hong Park, Isabelle Rivière, Xiuyan Wang, Brigitte Sénéchal, Yvette Bernal, Elizabeth Halton, Claudia Diamonte, Yongzeng Wang, Renier J. Brentjens, Michel Sadelain	6
9	Implications of Minimal Residual Disease Negative Complete Remission (MRD-CR) and Allogeneic Stem Cell Transplant on Safety and Clinical Outcome of CD19-Targeted 19-28z CAR Modified T Cells in Adult Patients with Relapsed, Refractory B-Cell ALL 2015 ·Blood ·Jae H. Park, Isabelle Rivière, Xiuyan Wang, Yvette Bernal, Terence J. Purdon, Elizabeth Halton, Yongzeng Wang, Kevin J. Curran, Craig S. Sauter, Michel Sadelain, Renier J. Brentjens	39
10	AtNOS/AtNOA1 Is a Functional Arabidopsis thaliana cGTPase and Not a Nitric-oxide Synthase 2008 ·Journal of Biological Chemistry ·Magali Moreau, (unknown), Yongzeng Wang, Brian R. Crane, Daniel F. Klessig	236
11	Tobamovirus infection is independent of HSP101 mRNA induction and protein expression 2006 ·Virus Research ·(unknown), Yongzeng Wang, Zhonglian Huang, Joanne M. Yeakley, Jian‐Bing Fan, Steven A. Whitham	15
12	O06. Assessing the involvement of NO and AtNOS1 in plant defense using GFP-reporter system and NO spin trapping 2006 ·Nitric Oxide ·Yongzeng Wang, (unknown), (unknown), Boris Dzikovski, James P. Shapleigh, Brian R. Crane, Daniel F. Klessig	1
13	Transgenic cucumbers harboring the 54-kDa putative gene of Cucumber fruit mottle mosaic tobamovirus are highly resistant to viral infection and protect non-transgenic scions from soil infection 2005 ·Transgenic Research ·Amit Gal‐On, Dalia Wolf, Y. Antignus, (unknown), Ki Hyun Ryu, B. E. Min, (unknown), Oded Lachman, Victor Gaba, Yongzeng Wang, Yoel Moshe Shiboleth, (unknown), Aaron Zelcer	33
14	Roles for host factors in plant viral pathogenicity 2004 ·Current Opinion in Plant Biology ·Steven A. Whitham, Yongzeng Wang	101
15	Functional analysis of the Cucumber mosaic virus 2b protein: pathogenicity and nuclear localization 2004 ·Journal of General Virology ·Yongzeng Wang, Tzvi Tzfira, Victor Gaba, Vitaly Citovsky, Peter Palukaitis, Amit Gal‐On	69
16	Characterization of Synergy Between Cucumber mosaic virus and Potyviruses in Cucurbit Hosts 2002 ·Phytopathology ·Yongzeng Wang, Victor Gaba, Jie Yang, Peter Palukaitis, Amit Gal‐On	104
17	A new approach for weed control in a cucurbit field employing an attenuated potyvirus-vector for herbicide resistance 2001 ·Journal of Biotechnology ·Yoel Moshe Shiboleth, Tzahi Arazi, Yongzeng Wang, Amit Gal‐On	21
18	Engineering zucchini yellow mosaic potyvirus as a non-pathogenic vector for expression of heterologous proteins in cucurbits 2001 ·Journal of Biotechnology ·Tzahi Arazi, Shalom Guy Slutsky, Yoel Moshe Shiboleth, Yongzeng Wang, Menachem Rubinstein, Sara Barak, Jie Yang, Amit Gal‐On	68
19	Identification of a Novel Plant Virus Promoter using a Potyvirus Infectious Clone 2000 ·Virus Genes ·Yongzeng Wang, Victor Gaba, Dalia Wolf, (unknown), Amit Gal‐On	14
20	Transgenic Resistance to Cucumber Mosaic Virus in Tomato: Blocking of Long-Distance Movement of the Virus in Lines Harboring a Defective Viral Replicase Gene 1998 ·Phytopathology ·Amit Gal‐On, Dalia Wolf, Yongzeng Wang, (unknown), M. Pilowsky, Aaron Zelcer	25

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact